These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23346101)

  • 1. 5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes.
    Nelson PM; Harrod JS; Lamping KG
    Exp Diabetes Res; 2012; 2012():398406. PubMed ID: 23346101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice.
    Nuno DW; Harrod JS; Lamping KG
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1469-77. PubMed ID: 19666843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of protein tyrosine phosphatases unmasks vasoconstriction and potentiates calcium signaling in rat aorta smooth muscle cells in response to an agonist of 5-HT2B receptors BW723C86.
    Mironova GY; Avdonin PP; Goncharov NV; Jenkins RO; Avdonin PV
    Biochem Biophys Res Commun; 2017 Jan; 483(1):700-705. PubMed ID: 27986565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.
    Booth RG; Fang L; Huang Y; Wilczynski A; Sivendran S
    Eur J Pharmacol; 2009 Aug; 615(1-3):1-9. PubMed ID: 19397907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced placental vascular reactivity to 5-hydroxytryptamine in pre-eclampsia and the status of 5HT(2A) receptors.
    Ugun-Klusek A; Tamang A; Loughna P; Billett E; Buckley G; Sivasubramaniam S
    Vascul Pharmacol; 2011; 55(5-6):157-62. PubMed ID: 21803171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying increased serotonin-induced contraction in carotid arteries from chronic type 2 diabetic Goto-Kakizaki rats.
    Matsumoto T; Watanabe S; Taguchi K; Kobayashi T
    Pharmacol Res; 2014 Sep; 87():123-32. PubMed ID: 25034165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
    Watts SW; Thompson JM
    J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-Dependent Control of Serotonin-Induced Pulmonary Arterial Contraction.
    Dahan D; Hien TT; Tannenberg P; Ekman M; Rippe C; Boettger T; Braun T; Tran-Lundmark K; Tran PK; Swärd K; Albinsson S
    J Vasc Res; 2017; 54(4):246-256. PubMed ID: 28796998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of serotonin 2A and 2B receptors in the mammalian respiratory network.
    Niebert M; Vogelgesang S; Koch UR; Bischoff AM; Kron M; Bock N; Manzke T
    PLoS One; 2011; 6(7):e21395. PubMed ID: 21789169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment.
    Enguix MJ; Sánchez L; Villazón M; Brea J; Tristán H; Caruncho HJ; Cadavid MI; Loza MI
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):79-90. PubMed ID: 12861437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts.
    Kodama A; Komori K; Kajikuri J; Itoh T
    J Vasc Surg; 2009 Sep; 50(3):617-25. PubMed ID: 19700096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of spinal 5-HT2 receptor subtypes in quipazine-induced hindlimb movements after a low-thoracic spinal cord transection.
    Ung RV; Landry ES; Rouleau P; Lapointe NP; Rouillard C; Guertin PA
    Eur J Neurosci; 2008 Dec; 28(11):2231-42. PubMed ID: 19019202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats.
    Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L
    Pharmacology; 2004 Jun; 71(2):66-72. PubMed ID: 15118345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of 5-HT(2B) receptors in the serotonin syndrome.
    Diaz SL; Maroteaux L
    Neuropharmacology; 2011 Sep; 61(3):495-502. PubMed ID: 21277875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors.
    Popa D; Léna C; Fabre V; Prenat C; Gingrich J; Escourrou P; Hamon M; Adrien J
    J Neurosci; 2005 Dec; 25(49):11231-8. PubMed ID: 16339018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.
    Halberstadt AL; van der Heijden I; Ruderman MA; Risbrough VB; Gingrich JA; Geyer MA; Powell SB
    Neuropsychopharmacology; 2009 Jul; 34(8):1958-67. PubMed ID: 19322172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bulky N6 substituent of cabergoline is responsible for agonism of this drug at 5-hydroxytryptamine 5-HT2A and 5-HT2B receptors and thus is a determinant of valvular heart disease.
    Kekewska A; Hübner H; Gmeiner P; Pertz HH
    J Pharmacol Exp Ther; 2011 Jul; 338(1):381-91. PubMed ID: 21518772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-mediated in vivo pressor responses following TRPV1 activation.
    Ohanyan VA; Guarini G; Thodeti CK; Talasila PK; Raman P; Haney RM; Meszaros JG; Damron DS; Bratz IN
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1135-42. PubMed ID: 21705674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.